» Articles » PMID: 24998560

Parthenolide-induced Apoptosis, Autophagy and Suppression of Proliferation in HepG2 Cells

Overview
Specialty Oncology
Date 2014 Jul 8
PMID 24998560
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate the anticancer effects and underlying mechanisms of parthenolide on HepG2 human hepatocellular carcinoma cells.

Materials And Methods: Cell viability was assessed by MTT assay and cell apoptosis through DAPI, TUNEL staining and Western blotting. Monodansylcadaverin(MDC) and AO staining were used to detect cell autophagy. Cell proliferation was assessed by Ki67 immunofluorescence staining.

Results: Parthenolide induced growth inhibition in HepG2 cells. DAPI and TUNEL staining showed that parthenolide could increase the number of apoptotic nuclei, while reducing the expression of the anti-apoptotic protein Bcl-2 and elevating the expression of related proteins, like p53, Bax, cleaved caspase9 and cleaved caspase3. Parthenolide could induce autophagy in HepG2 cells and inhibited the expression of proliferation-related gene, Ki-67.

Conclusions: Parthenolide can exert anti-cancer effects by inducing cell apoptosis, activating autophagy and inhibiting cell proliferation.

Citing Articles

A Study of the Chemical Composition, Acute and Subacute Toxicity of Bulgarian Essential Oil.

Lechkova B, Karcheva-Bahchevanska D, Ivanov K, Todorova V, Benbassat N, Penkova N Molecules. 2023; 28(13).

PMID: 37446568 PMC: 10343533. DOI: 10.3390/molecules28134906.


Parthenolide induces rapid thiol oxidation that leads to ferroptosis in hepatocellular carcinoma cells.

LoBianco F, Krager K, Johnson E, Godwin C, Allen A, Crooks P Front Toxicol. 2023; 4:936149.

PMID: 36591540 PMC: 9795200. DOI: 10.3389/ftox.2022.936149.


The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy.

An T, Yin H, Lu Y, Liu F Drug Des Devel Ther. 2022; 16:1255-1272.

PMID: 35517982 PMC: 9063801. DOI: 10.2147/DDDT.S355059.


Parthenolide leads to proteomic differences in thyroid cancer cells and promotes apoptosis.

Cui M, Wang Z, Huang L, Wang J BMC Complement Med Ther. 2022; 22(1):99.

PMID: 35366876 PMC: 8977004. DOI: 10.1186/s12906-022-03579-0.


Roles of Therapeutic Bioactive Compounds in Hepatocellular Carcinoma.

Jain D, Murti Y, Khan W, Hossain R, Hossain M, Agrawal K Oxid Med Cell Longev. 2021; 2021:9068850.

PMID: 34754365 PMC: 8572616. DOI: 10.1155/2021/9068850.